JP2017131682A5 - - Google Patents

Download PDF

Info

Publication number
JP2017131682A5
JP2017131682A5 JP2017050041A JP2017050041A JP2017131682A5 JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5 JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5
Authority
JP
Japan
Prior art keywords
cells
hours
liver
found
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017050041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017131682A (ja
JP6891010B2 (ja
Filing date
Publication date
Priority claimed from JP2013509287A external-priority patent/JP6177687B2/ja
Application filed filed Critical
Publication of JP2017131682A publication Critical patent/JP2017131682A/ja
Priority to JP2019113597A priority Critical patent/JP6987811B2/ja
Publication of JP2017131682A5 publication Critical patent/JP2017131682A5/ja
Application granted granted Critical
Publication of JP6891010B2 publication Critical patent/JP6891010B2/ja
Priority to JP2021194048A priority patent/JP7358441B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017050041A 2010-05-07 2017-03-15 実質組織からの細胞の移植方法 Expired - Fee Related JP6891010B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019113597A JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33244110P 2010-05-07 2010-05-07
US61/332,441 2010-05-07
JP2013509287A JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013509287A Division JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019113597A Division JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法

Publications (3)

Publication Number Publication Date
JP2017131682A JP2017131682A (ja) 2017-08-03
JP2017131682A5 true JP2017131682A5 (enExample) 2019-08-08
JP6891010B2 JP6891010B2 (ja) 2021-06-18

Family

ID=44902076

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用
JP2017050041A Expired - Fee Related JP6891010B2 (ja) 2010-05-07 2017-03-15 実質組織からの細胞の移植方法
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Country Status (19)

Country Link
US (1) US20110274666A1 (enExample)
EP (1) EP2566567A4 (enExample)
JP (4) JP6177687B2 (enExample)
KR (4) KR20130108996A (enExample)
CN (2) CN102985130A (enExample)
AR (1) AR081906A1 (enExample)
AU (1) AU2011247984B2 (enExample)
BR (1) BR112012028265B1 (enExample)
CA (2) CA3146949A1 (enExample)
CL (1) CL2012003085A1 (enExample)
CR (1) CR20120603A (enExample)
IL (3) IL222857A (enExample)
MX (3) MX359678B (enExample)
NZ (2) NZ603913A (enExample)
PH (1) PH12012502176A1 (enExample)
RU (1) RU2736955C2 (enExample)
SG (2) SG10201503582YA (enExample)
TW (3) TW202006136A (enExample)
WO (1) WO2011140428A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9533013B2 (en) * 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
EP2886644A1 (en) * 2013-12-20 2015-06-24 Kallistem Process for implementing in vitro spermatogenesis and associated device
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
WO2016118950A1 (en) * 2015-01-23 2016-07-28 Everon Biosciences, Inc. Induction of cellular senescence for tissue therapies
CN106148266A (zh) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 一种免疫细胞用培养基及该培养基的添加剂
JP2016209303A (ja) * 2015-05-08 2016-12-15 レジエンス株式会社 肝組織を再生するための製剤
US20170369849A1 (en) * 2016-05-11 2017-12-28 The University Of North Carolina At Chapel Hill Compositions and methods for bioengineered tissues
US11160271B2 (en) 2016-09-30 2021-11-02 Taipei Veterans General Hospital Anti-freezing agent for protecting biological tissue during freezing treatment and preparation method therefor
CN110913691A (zh) * 2017-04-06 2020-03-24 北卡罗来纳大学教堂山分校 低温保存方法
AU2018282728B2 (en) 2017-06-12 2024-12-12 The University Of North Carolina At Chapel Hill Patch graft compositions for cell engraftment
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
JP2020050625A (ja) * 2018-09-27 2020-04-02 株式会社北里コーポレーション 卵巣組織の移植方法および卵胞活性化方法
JP7350505B2 (ja) * 2019-02-15 2023-09-26 イビデン株式会社 生体試料を含む固化体
WO2021060380A1 (ja) * 2019-09-27 2021-04-01 公立大学法人横浜市立大学 肝細胞の可塑性誘導法
JPWO2023042875A1 (enExample) * 2021-09-16 2023-03-23
US20250154453A1 (en) * 2021-12-28 2025-05-15 Pormedtec Co., Ltd. Method for producing transplant material, and transplant material
KR20250056904A (ko) * 2022-08-24 2025-04-28 가부시키가이샤 비타 형광 표지용 조성물, 형광 프로브, 주입제, 시린지 충전물, 의료 기구, 의료용 섬유 소재, 형광 표지용 조성물의 제조 방법 및 의료용 섬유 소재의 제조 방법
CN116920263A (zh) * 2023-07-28 2023-10-24 南方医科大学南方医院 一种透皮递送活体干细胞的冷冻微针及其制备方法和应用
CN117426368A (zh) * 2023-10-08 2024-01-23 北京汇智泰康医药技术有限公司 一种肝细胞冻存液及其应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US20040138329A1 (en) * 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
CA2140905A1 (en) * 1992-07-29 1994-01-30 Keith E. Dionne Use of pouch of implantation of living cells
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
AU3214797A (en) * 1996-05-28 1998-01-05 Regents Of The University Of Michigan, The Engineering oral tissues
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP3014343B2 (ja) * 1997-06-06 2000-02-28 科学技術振興事業団 肝細胞の培養方法
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
US20020182188A1 (en) * 1999-01-19 2002-12-05 Reid Lola M. Human liver progenitors
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
ATE288478T1 (de) * 1999-04-30 2005-02-15 Massachusetts Gen Hospital Herstellung von dreidimensionalem vaskularisierten gewebe mittels der verwendung von zweidimensionalen mikrohergestellten formen
US6660905B1 (en) * 1999-07-14 2003-12-09 The Board Of Trustees Of The Leland Stanford Junior University Mice comprising engrafted functional human hepatocytes
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
RU2165263C1 (ru) * 2000-06-23 2001-04-20 Зыбин Дмитрий Владимирович Способ лечения сахарного диабета
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6435190B1 (en) * 2000-06-14 2002-08-20 Syde A. Taheri Autogenous cell patch cardio myoplasty and advanced muscle graft implantation system
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
CA2430130A1 (en) * 2000-11-28 2002-06-06 Focal, Inc. Polyalkylene glycol viscosity-enhancing polymeric formulations
US20030077566A1 (en) * 2001-09-10 2003-04-24 Palasz Andrzej T. Method for cryopreserving mammalian cells and tissues
JP2005534430A (ja) * 2002-08-06 2005-11-17 ジェンベック， インコーポレイテッド 改良された注射システム
US7319035B2 (en) * 2002-10-17 2008-01-15 Vbi Technologies, L.L.C. Biological scaffolding material
KR20060032953A (ko) * 2003-05-08 2006-04-18 셀라티스 에이비 폐쇄된 스트로 초자화 방법의 사용에 의한 인간 배반포에서유래된 줄기 세포의 동결 보존
JP2007503840A (ja) * 2003-09-02 2007-03-01 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解性ポリマー−リガンド結合体、及び、細胞亜集団の単離、細胞の凍結保存、培養及び移植に生分解性ポリマー−リガンド結合体を用いる方法
CN1863903A (zh) * 2003-09-19 2006-11-15 新南部创新有限公司 分离肝细胞的方法
WO2005056763A2 (en) * 2003-12-04 2005-06-23 University Of Utah Research Foundation Process and formulation to improve viability of stored cells and tissue
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
RU2008124158A (ru) * 2005-11-16 2010-01-10 Юниверсити Оф Норт Каролина Эт Чепел Хилл (Us) Внеклеточные матриксные компоненты для экспансии и дифференцировки гепатических клеток-предшественников
WO2007138119A1 (es) * 2006-05-30 2007-12-06 Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria, Inia Procedimiento de preparación de vesículas unilamelares para la criopreservación y cultivo de celulas germinales y embriones
TW200817019A (en) * 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
US8084055B2 (en) * 2006-09-21 2011-12-27 Purdue Research Foundation Collagen preparation and method of isolation
WO2008101215A1 (en) * 2007-02-16 2008-08-21 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo
CA2680254A1 (en) * 2007-03-06 2008-09-12 University Of North Carolina At Chapel Hill Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of hepatic cells
US20080299177A1 (en) * 2007-06-06 2008-12-04 Biovaluation & Analysis, Inc. Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
CA2727535A1 (en) * 2007-06-15 2008-12-24 University Of North Carolina At Chapel Hill Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
GB0713079D0 (en) * 2007-07-05 2007-08-15 Ucl Business Plc biomaterial scaffolds with defined stiffness
AU2008288093A1 (en) * 2007-08-15 2009-02-19 Ramot At Tel Aviv University Ltd. Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
CA2696698A1 (en) * 2007-08-20 2009-02-26 Do-Coop Technologies Ltd. Enriched nanostructure composition
EP2222159B1 (en) * 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
CN101618235A (zh) * 2008-07-01 2010-01-06 中国人民解放军军事医学科学院基础医学研究所 一种基于opf水凝胶为液态支架的可注射性心肌组织工程产品
JP5702723B2 (ja) * 2008-09-04 2015-04-15 ザ ジェネラル ホスピタル コーポレイション 声帯および軟組織の増強および修復用ヒドロゲル
US20100092533A1 (en) * 2008-10-15 2010-04-15 Joshua Stopek Bioabsorbable Surgical Composition
EP2221362A1 (en) * 2009-02-19 2010-08-25 Naturin GmbH & Co Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies

Similar Documents

Publication Publication Date Title
JP2017131682A5 (enExample)
CL2012002882A1 (es) Compuestos derivados de 5,7- sustituido -imidazol [1,2-c] pirimidinas, inhibidores de jak-quinasa; proceso de preparacion; composicion farmaceutica; y su uso para tratar una enfermedad autoinmunitaria o inflamatoria, el rechazo de transplante de organos, tejidos o celulas en un mamifero.
WO2012021845A3 (en) Improved hematopoietic stem and progenitor cell therapy
WO2012048010A3 (en) Compositions of adult organ stem cells and uses thereof
JP2018518943A5 (enExample)
HK1249534A1 (zh) 用於非清髓性预处理的组合物和方法
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
HK1212388A1 (en) Methods of tissue generation
JP2014501518A5 (enExample)
WO2011106322A3 (en) Biomarkers for acute ischemic stroke
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
JP2016500260A5 (enExample)
WO2007011797A3 (en) Immunophenotype and immunogenicity of human adipose derived cells
WO2017105565A3 (en) Compositions for therapeutics, targeted pet imaging and methods of their use
WO2017015245A8 (en) Methods and compositions for stem cell transplantation
IL260210B2 (en) cftr regulators and methods of using them
WO2016191179A8 (en) In vitro models of regenerative muscle cell therapy and uses thereof
WO2015076717A3 (en) Mscs in the treatment of cardiac disorders
MX373950B (es) USO DE UN INHIBIDOR TEMPORAL DE UN GEN p53 PARA LA PROFILAXIS DE LESIÓN POR ISQUEMIA-REPERFUSIÓN.
BR112012030015A2 (pt) composição para a preservação de órgãos a frio, método para a preparação de uma composição de preservação de órgãos a frio, uso da cardiotrofina-1 ou uma variante equivalente funcionalmente da mesma, método para a preservação de órgãos a frio, órgão isolado preservado a frio e kit para a preparação de uma composição para a preservação de órgãos a frio
JP2016510766A5 (enExample)
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
CY1112746T1 (el) Κρυοσυντηρηση ηπατοκυτταρων
JP2010166901A5 (enExample)
RU2011103549A (ru) Предшественник искусственной почки и способ его получения